Cargando…
Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy
SIMPLE SUMMARY: pN1 after RP with PLND represents one of the most unfavorable prognostic factors for disease recurrence and cancer-specific mortality in prostate cancer. Treatment intensification may reduce risks of recurrence and cancer-specific mortality, but it may increase adverse events and imp...
Autores principales: | Shiota, Masaki, Blas, Leandro, Eto, Masatoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179902/ https://www.ncbi.nlm.nih.gov/pubmed/35681676 http://dx.doi.org/10.3390/cancers14112696 |
Ejemplares similares
-
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
por: Blas, Leandro, et al.
Publicado: (2022) -
Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician’s Perspective
por: Matsumoto, Takashi, et al.
Publicado: (2022) -
Extended lymph node dissection in robotic radical prostatectomy: Current status
por: Chopra, Sameer, et al.
Publicado: (2016) -
Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
por: Akitake, Naoko, et al.
Publicado: (2018) -
The Role of Radical Prostatectomy and Lymph Node Dissection in Clinically Node Positive Patients
por: Motterle, Giovanni, et al.
Publicado: (2019)